Skip to main content
. 2020 Jan 30;11:619. doi: 10.1038/s41467-020-14373-2

Fig. 1. CSF LCN2 in the differential diagnosis of dementia (cohort 1).

Fig. 1

a LCN2 in non-primarily neurodegenerative and non-ischemic neuropsychiatric diseases (ND, n = 73), Alzheimer’s disease (AD, n = 47), vascular dementia (VaD, n = 27), mixed Alzheimer’s and vascular dementia (MD, n = 31), Lewy body dementias (LBD, n = 36), frontotemporal dementia (FTD, n = 21), and sporadic Creutzfeldt-Jakob disease (CJD, n = 54). Results are shown as mean ± SD for each condition. b Area under the curve (AUC) derived from receiver operating characteristic (ROC) curves, Standard Error (SE), 95% Confidence interval (95% CI) for LCN2 in the comparative analyses. c ROC curves of differentiating ND and VaD as well as AD and VaD. Differences between groups were analysed with Tukey contrasts using linear regression models controlled for age and sex. *p < 0.05, **p < 0.01, ***p < 0.001.